Incyte Corp
Change company Symbol lookup
Select an option...
INCY Incyte Corp
TYGO Tigo Energy Inc
ERAS Erasca Inc
MEOH Methanex Corp
CADL Candel Therapeutics Inc
YECO Yulong Eco-Materials Ltd
ZVOI Zovio Inc
YEXT Yext Inc
ZNOG Zion Oil and Gas Inc
PM Philip Morris International Inc
Go

Health Care : Biotechnology | Mid Cap Growth

Incyte Corporation is a biopharmaceutical company, which is focused on the discovery, development, and commercialization of therapeutics. The Company also conducts commercial and clinical development operations from its European headquarters in Morges, Switzerland, and Japanese office in Tokyo and Canadian headquarters in Montreal. It operates in two therapeutic areas, One therapeutic area is Hematology/Oncology, which is comprised of Myeloproliferative Neoplasms and Graft-Versus-Host Disease, as well as solid tumors and hematologic malignancies. The other therapeutic area is Inflammation and Autoimmunity, which includes its Dermatology commercial franchise. Its hematology and oncology franchise are comprised of four products, which are JAKAFI (ruxolitinib), MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab), PEMAZYRE (pemigatinib) and ICLUSIG (ponatinib), as well as other clinical development programs. Its Dermatology commercial franchise is comprised of OPZELURA (ruxolitinib) cream.

Postmarket

Last Trade: Delayed
$61.39

Change Since Close Change Since Close Postmarket extended hours change is based on the last price at the end of the regular hours period. Premarket extended hours change is based on the day's regular session close.: 0.00 (0.00%)

Bid: --

Ask: --

B/A Size: --

Market Hours

Closing Price: $61.39

Day's Change: -0.32 (-0.52%)

Bid close: --

Ask close: --

B/A Size: --

Day's High: 61.90

Day's Low: 61.01

Volume (Below Average) Volume: 1,648,146 10-day average volume: 1,884,893: 1,648,146

Today's News, June 07, 2023
5:15 pm ET	Incyte Corp. Stock Falls Wednesday, Underperforms Market This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Incyte Corp. (INCY) slumped 0.52% to $61.39 Wednesday, on what proved to be an all-around mixed trading session for the stock...(MarketWatch)
Yesterday's News, June 06, 2023
5:15 pm ET	Incyte Corp. Stock Underperforms Tuesday When Compared To Competitors This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Incyte Corp. (INCY) slipped 1.06% to $61.71 Tuesday, on what proved to be an all-around great trading session for the stock market...(MarketWatch)
June 05, 2023
5:13 pm ET	Incyte Corp. Stock Falls Monday, Underperforms Market This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Incyte Corp. (INCY) slumped 0.27% to $62.37 Monday, on what proved to be an all-around dismal trading session for the stock market...(MarketWatch)
June 02, 2023
5:15 pm ET	Incyte Corp. Stock Outperforms Market On Strong Trading Day This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Incyte Corp. (INCY) advanced 1.67% to $62.54 Friday, on what proved to be an all-around positive trading session for the stock...(MarketWatch)
June 01, 2023
5:02 pm ET	Incyte Corp. Stock Falls Thursday, Underperforms Market This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Incyte Corp. (INCY) slumped 0.06% to $61.51 Thursday, on what proved to be an all-around positive trading session for the stock...(MarketWatch)
May 31, 2023
5:02 pm ET	Incyte Corp. Stock Underperforms Wednesday When Compared To Competitors This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Incyte Corp. (INCY) slipped 0.52% to $61.55 Wednesday, on what proved to be an all-around rough trading session for the stock...(MarketWatch)
May 30, 2023
5:02 pm ET	Incyte Corp. Stock Falls Tuesday, Underperforms Market This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Incyte Corp. (INCY) slipped 1.13% to $61.87 Tuesday, on what proved to be an all-around mixed trading session for the stock market...(MarketWatch)
May 26, 2023
5:02 pm ET	Incyte Corp. Stock Outperforms Competitors Despite Losses On The Day This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Incyte Corp. (INCY) dropped 0.46% to $62.58 Friday, on what proved to be an all-around great trading session for the stock market...(MarketWatch)
May 25, 2023
5:03 pm ET	Incyte Corp. Stock Falls Thursday, Underperforms Market This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Incyte Corp. (INCY) slid 2.19% to $62.87 Thursday, on what proved to be an all-around mixed trading session for the stock market...(MarketWatch)
5:01 pm ET	Data from Across Incyte's Oncology Portfolio Accepted for Presentation at the 2023 ASCO Annual Meeting and EHA2023 Hybrid Congress Incyte (Nasdaq:INCY) today announced that multiple abstracts featuring data from across its oncology portfolio will be presented at the upcoming 2023 American Society of Clinical Oncology (ASCO) Annual Meeting held June 2-6 in Chicago, and at the...(BusinessWire)
May 24, 2023
5:02 pm ET	Incyte Corp. Stock Falls Wednesday, Underperforms Market This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Incyte Corp. (INCY) slipped 1.23% to $64.28 Wednesday, on what proved to be an all-around grim trading session for the stock...(MarketWatch)
May 23, 2023
5:02 pm ET	Incyte Corp. Stock Outperforms Market On Strong Trading Day This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Incyte Corp. (INCY) advanced 1.07% to $65.08 Tuesday, on what proved to be an all-around rough trading session for the stock...(MarketWatch)
8:00 am ET	Incyte to Present at Upcoming Investor Conferences Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of June: William Blair 43rd Annual Growth Stock Conference on Tuesday, June 6, 2023 at 11:20 a.m. (CDT) Goldman Sachs 44th Annual...(BusinessWire)
May 22, 2023
5:02 pm ET	Incyte Corp. Stock Outperforms Market On Strong Trading Day This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Incyte Corp. (INCY) rallied 1.29% to $64.39 Monday, on what proved to be an all-around mixed trading session for the stock market...(MarketWatch)
May 19, 2023
5:01 pm ET	Incyte Corp. Stock Falls Friday, Still Outperforms Market This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Incyte Corp. (INCY) sank 0.09% to $63.57 Friday, on what proved to be an all-around dismal trading session for the stock market...(MarketWatch)
May 18, 2023
5:02 pm ET	Incyte Corp. Stock Underperforms Thursday When Compared To Competitors This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Incyte Corp. (INCY) slipped 1.43% to $63.63 Thursday, on what proved to be an all-around positive trading session for the stock...(MarketWatch)
May 17, 2023
5:02 pm ET	Incyte Corp. Stock Underperforms Wednesday When Compared To Competitors This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Incyte Corp. (INCY) shed 0.23% to $64.55 Wednesday, on what proved to be an all-around positive trading session for the stock...(MarketWatch)
May 16, 2023
5:02 pm ET	Incyte Corp. Stock Outperforms Competitors Despite Losses On The Day This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Incyte Corp. (INCY) slid 2.27% to $64.70 Tuesday, on what proved to be an all-around rough trading session for the stock market...(MarketWatch)
May 15, 2023
5:02 pm ET	Incyte Corp. Stock Outperforms Competitors On Strong Trading Day This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Incyte Corp. (INCY) rose 1.41% to $66.20 Monday, on what proved to be an all-around great trading session for the stock market...(MarketWatch)
May 12, 2023
5:02 pm ET	Incyte Corp. Stock Outperforms Competitors On Strong Trading Day This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Incyte Corp. (INCY) rose 1.73% to $65.28 Friday, on what proved to be an all-around grim trading session for the stock market, with...(MarketWatch)
Next >

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for varies.

Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Postmarket

Change Since Close

Market Hours